The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
A Comparison of Magnesium Sulfate and Nimodipine for the Prevention of Eclampsia
Open accessAbstract
OBJECTIVE: Magnesium sulfate may prevent eclampsia by reducing cerebral vasoconstriction and ischemia. Nimodipine is a calcium-channel blocker with specific cerebral vasodilator activity. Our objective was to determine whether nimodipine is more effective than magnesium sulfate for seizure prophylaxis in women with severe preeclampsia. METHODS: We conducted an unblinded, multicenter trial in which 1650 women with severe preeclampsia were randomly assigned to receive either nimodipine (60 mg orally every 4 hours) or intravenous magnesium sulfate (given according to the institutional protocol) from enrollment until 24 hours post partum. High blood pressure was controlled with intravenous hydralazine as needed. The primary outcome measure was the development of eclampsia, as defined by a witnessed tonic-clonic seizure. RESULTS: Demographic and clinical characteristics were similar in the two groups. The women who received nimodipine were more likely to have a seizure than those who received magnesium sulfate (21 of 819 [2.6 percent] vs. 7 of 831 [0.8 percent], P=0.01). The adjusted risk ratio for eclampsia associated with nimodipine, as compared with magnesium sulfate, was 3.2 (95 percent confidence interval, 1.1 to 9.1). The antepartum seizure rates did not differ significantly between groups, but the nimodipine group had a higher rate of postpartum seizures (9 of 819 [1.1 percent] vs. 0 of 831, P=0.01). There were no significant differences in neonatal outcome between the two groups. More women in the magnesium sulfate group than in the nimodipine group needed hydralazine to control blood pressure (54.3 percent vs. 45.7 percent, P<0.001). CONCLUSIONS: Magnesium sulfate is more effective than nimodipine for prophylaxis against seizures in women with severe preeclampsia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Statistical Methods for Rates and Proportions, 2nd ed
GROVE, W. A. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.12.1644-a · Cited by 3,748
Subarachnoid haemorrhage: diagnosis, causes and management
van Gijn, J., & Rinkel, G. J. E. (2001) · Brain · doi:10.1093/brain/124.2.249 · Cited by 1,353
Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial
The Eclampsia Trial Collaborative Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)91034-4 · Cited by 831
"Which Anticonvulsant for Women with Eclampsia? Evidence from the Collaborative Eclampsia Trial."
(1995) · Studies in Family Planning · doi:10.2307/2138105 · Cited by 735
A Comparison of Magnesium Sulfate with Phenytoin for the Prevention of Eclampsia
Lucas, M. J., Leveno, K. J., & Cunningham, F. G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330401 · Cited by 539
Coetzee, E. J., Dommisse, J., & Anthony, J. (1998) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10090.x · Cited by 187
Self-citationBelfort, M. A., & Moise, K. J. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)91567-1 · Cited by 187
Self-citationMagnesium sulfate is the ideal anticonvulsant inpreeclampsia-eclampsia
Sibai, B. M. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90002-o · Cited by 168
Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy.
Richards, A., Graham, D. I., & Bullock, R. M. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.3.416 · Cited by 138
Cotton, D. B., Gonik, B., & Dorman, K. F. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(84)80169-6 · Cited by 121
Cerebral blood flow and cranial magnetic resonance imaging in eclampsia and severe preeclampsia
CRAIGMORRISS, M., Twickler, D. M., Hatab, M. R., CLARKE, G., Peshock, R. M., & GARYCUNNINGHAM, F. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00048-3 · Cited by 93
Panchal, S., Arria, A. M., & Labhsetwar, S. A. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200107000-00028 · Cited by 66
Autacoids and the control of vascular tone in the human umbilical-placental circulation
Boura, A. L. A., & Walters, W. A. W. (1991) · Placenta · doi:10.1016/0143-4004(91)90023-9 · Cited by 59
Maternal Mortality Associated with Eclampsia and Severe Preeclampsia of Pregnancy
Sawhney, H., Aggarwal, N., Biswas, R., et al. (2000) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2000.tb01338.x · Cited by 41
An outcomes management program in gynecologic oncology
MORRIS, M., Lev́enback, C., Burke, T., DeJesus, Y. A., LUCAS, K., & Gershenson, D. M. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00008-2 · Cited by 35
Cited by
Gestational Hypertension and Preeclampsia
(2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003891 · Cited by 2,949
Magnesium in Prevention and Therapy
Gröber, U., Schmidt, J., & Kisters, K. (2015) · Nutrients · doi:10.3390/nu7095388 · Cited by 1,061
(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003018 · Cited by 878
Magnesium sulphate and other anticonvulsants for women with pre-eclampsia
Duley, L., Gülmezoglu, A. M., Henderson-Smart, D. J., & Chou, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000025.pub2 · Cited by 586
RETIRED: Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy
Magee, L. A., Helewa, M., Rey, E., Cardew, S., Côté, A.-M., Douglas, M. J., Firoz, T., Gibson, P. S., Gruslin A., A., Lange, I., et al. (2008) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32776-1 · Cited by 578
Metadata
- Authors
- Belfort, M. A., Anthony, J., Saade, G. R., & Allen, J. C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-01-23
- Volume
- 348
- Issue
- 4
- Pages
- 304-311
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2121218152
- Cited by
- 279
- References
- 17
- FWCI
- 28.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.